Name | 8-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one |
---|---|
Synonyms |
L-803,087 trifluoroacetate
Espiroxatrina MFCD00055134 R 5188 spiroxatriene Spiroxatrinum Spiroxatrine |
Description | Spiroxatrine (R 5188) is a selective, dual antagonist of 5-HT1α and α2-adrenergic, with the Ki values of 3.94, 224000, 118.5 nM for 5-HT1α,5-HT1β and 5-HT2,respectively. Spiroxatrine (R 5188) has a sedative effect[1][2][3][4]. |
---|---|
Related Catalog | |
Target |
α2-adrenergic receptor 5-HT1A Receptor:3.94 nM (Ki) 5-HT1B/D Receptor:224000 nM (Ki) 5-HT2 Receptor:118.5 nM (Ki) |
References |
Density | 1.32g/cm3 |
---|---|
Boiling Point | 602.8ºC at 760mmHg |
Molecular Formula | C22H25N3O3 |
Molecular Weight | 379.45 |
Flash Point | 318.4ºC |
Exact Mass | 379.19000 |
PSA | 54.04000 |
LogP | 2.58660 |
Vapour Pressure | 1.74E-14mmHg at 25°C |
Index of Refraction | 1.665 |
WGK Germany | 3 |
---|